Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy.

Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy.

Item
http://www.wikidata.org/entity/Q37462524
Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer.Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients.PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomyExcellent response to chemotherapy post immunotherapy.Combining DNA damaging therapeutics with immunotherapy: more haste, less speed.Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer.PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression.Anti PD-L1 combined with other agents in non-small cell lung cancer: combinations with non-immuno-oncology agents.Single nucleotide polymorphisms of casitas B-lineage lymphoma proto-oncogene-b predict outcomes of patients with advanced non-small cell lung cancer after first-line platinum based doublet chemotherapy.Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK ActivationMoving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189
P2860

Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy.

Item
http://www.wikidata.org/entity/Q37462524
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Upregulation of programmed cel ...... ith neo-adjuvant chemotherapy.
@en
Upregulation of programmed cel ...... ith neo-adjuvant chemotherapy.
@nl
type
label
Upregulation of programmed cel ...... ith neo-adjuvant chemotherapy.
@en
Upregulation of programmed cel ...... ith neo-adjuvant chemotherapy.
@nl
prefLabel
Upregulation of programmed cel ...... ith neo-adjuvant chemotherapy.
@en
Upregulation of programmed cel ...... ith neo-adjuvant chemotherapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Upregulation of programmed cel ...... ith neo-adjuvant chemotherapy.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932